Investor Spotlight: Super Capital Co-Founder Corentin Orsini
Sparked by a newsletter from a former tech journalist, Super Capital has grown into a network of 1,000 investors with 180 companies in its portfolio.
French Tech News: How LumApps Kicked Down The Exit Door
Also inside: XMOBILITY CEO Magali Alix-Toupé revs up the engine of her new Le Mans accelerator.
Exit Lessons From Bridgepoint's $650M Buyout of LumApps
Buyouts by PE firms may be the best hope for the exits that the French ecosystem craves. LumApps CEO Sébastien Ricard and Bridgepoint partner David Nicault break down the metrics that made this deal work.
Seed Scout #16: Adaptive ML Promises To Fix Enterprise GenAI Fails
Also inside: Etienne Boutan breaks down the strategy behind Intuition, a €15 million early-stage fund focused on consumer and creator tech; and Hot Seed Deals.
Investor Spotlight: Intuition Partner Etienne Boutan
On starting a €15m consumer tech fund: “If you're a consumer investor and you're backing early-stage deals, there's no competition."
Seed Of The Week: Adaptive ML
The startup has raised $20 million to develop a tool that helps enterprises rapidly optimize their deployment of GenAI-powered services.
French Tech News: VivaTech-A-Palooza
It's VivaTech time. We give you a rundown of the 21 French startups with unicorn potential; Plus a Q&A with one of the conference's founders.
VivaTech: 21 Future French Unicorns
VivaTech has anointed its Top 100 Next Unicorns for the latest edition of the conference. Here's the rundown of the French candidates who hope to be the Next Big Thing.
The Big Deals 💣 : Resilience, H, And May Health
GenAI (of course), and MedTech get new checks.
Seed Scout #15: Avatar Medical Visualizes Healthcare's 3D Future
Also inside: Masawa Managing Partner Sabine Flechet discusses the new mental health early-stage fund; and Seed Deals.
Investor Spotlight: Masawa Partner Sabine Flechet
Munich-based Sabine Flechet is a prominent Business Angel who launched an early-stage fund that backs mental-health startups but also supports the mental health of founders through its approach dubbed, "Nurture Capital."
French Tech News: SNCF Digital Plans Go Full Steam Ahead
Also inside: How Qubit Pharmaceuticals will use quantum computing to reinvent drug discovery; AI startups continue to make VCs swoon.
The Big Deals 💣 : FlexAI, Payflows, And BforeAI
AI continues to be a money magnet while B2B fintech gets a nod.
Spotlight Interview: Qubit Pharmaceuticals' Robert Marino And Jean-Philip Piquemal
Piquemal on the future of drug discovery: "Quantum computing will be...capable of predicting quickly and with accuracy the chemical processes we are looking at. And if we can predict, we can go faster."
Seed Scout #14: Kolet's eSIM Plot To Reinvent Telecom Services
Also inside: Serena Partner Bertrand Diard breaks down the firm's new €100m Data and AI fund; and the latest Seed Deals.